Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vlad Țâru
Observed names:
V Taru,
Vlad Taru
Institutions:
Iuliu Hațieganu University of Medicine and Pharmacy,
Institutul Regional de Gastroenterologie Prof. Dr. Octavian Fodor,
Medical University of Vienna
Observed institutions:
Iuliu Hațieganu University of Medicine and Pharmacy,
Institutul Regional de Gastroenterologie Prof. Dr. Octavian Fodor,
Medical University of Vienna,
University of Bologna
ORCID:
0000-0002-2313-7881
Observed ORCID:
0000-0002-2313-7881
OpenAlex ID:
A5035209476
Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation
2024
·
Vlad Taru
, Gyongyi Szabo
, et al.
·
Journal of Hepatology
·
395
Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD
2024
·
Rafael Paternostro
, Wilhelmus J. Kwanten
, et al.
·
Journal of Hepatology
·
87
PDF
How to Identify Advanced Fibrosis in Adult Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Using Ultrasound Elastography—A Review of the Literature and Proposed Multistep Approach
2023
·
Madalina-Gabriela Taru
, Lidia Neamti
, et al.
·
Diagnostics
·
31
PDF
FAST and Agile–the MASLD drift: Validation of Agile 3+, Agile 4 and FAST scores in 246 biopsy-proven NAFLD patients meeting MASLD criteria of prevalent caucasian origin
2024
·
Madalina-Gabriela Taru
, Cristian Tefas
, et al.
·
PLoS ONE
·
24
Inflammation remains a dynamic component of portal hypertension in regressive alcohol‐related cirrhosis
2024
·
Benedikt Silvester Hofer
, Benedikt Simbrunner
, et al.
·
United European Gastroenterology Journal
·
9
PDF
Validation and Performance of Chronic Liver Disease Questionnaire (CLDQ-RO) in the Romanian Population
2021
·
Vlad Taru
, Madalin Gabriela Indre
, et al.
·
Journal of Gastrointestinal and Liver Diseases
·
8
PDF
Molecular patterns of the NO-sGC-cGMP pathway in progressive and regressive liver fibrosis models
2025
·
Thomas Sorz-Nechay
, Ksenia Brusilovskaya
, et al.
·
Scientific Reports
·
5
PDF
Aetiology-specific inflammation patterns in patients and rat models of compensated cirrhosis
2024
·
Benedikt Silvester Hofer
, Benedikt Simbrunner
, et al.
·
Digestive and Liver Disease
·
5
PDF
Impact of Underlying Portal Hypertension on Severity and Course of Acute‐On‐Chronic Liver Failure
2025
·
Vlad Taru
, Georg Kramer
, et al.
·
Liver International
·
4
PDF
Non-dental oral cavity findings in gastroesophageal reflux disease: a systematic review and meta-analysis
2021
·
Madalina-Gabriela Indre
, Darius Sampelean
, et al.
·
Journal of Mind and Medical Sciences
·
4
PDF
Pancreatic involvement and its prognostic impact in acute-on-chronic liver failure
2025
·
Georg Kramer
, Vlad Taru
, et al.
·
Annals of Hepatology
·
2
Recently validated non-invasive tests for liver fibrosis assessment have great performance in identifying NASH patients at risk for decompensation
2023
·
Vlad Taru
, Madalina Gabriela Taru
, et al.
·
Journal of Hepatology
·
2
Neuroendocrine carcinoma of the breast: a case report
2021
·
Iulia Gîvan
, George Ciulei
, et al.
·
Journal of Mind and Medical Sciences
·
2
PDF
A HDL-based cirrhosis risk score improves the prediction of short-term mortality in acutely decompensated cirrhosis
2026
·
Rudolf E. Stauber
, Eva M. Usón-Raposo
, et al.
·
Liver Transplantation
·
1
Reply to: “Pyroptosis in liver failure: A twisted firestarter”
2024
·
Vlad Taru
, Thomas Reiberger
·
Journal of Hepatology
·
1
PDF
Natural history of patients with NAFLD-associated compensated advanced chronic liver disease stratified according to severity of portal hypertension
2023
·
Rafael Paternostro
, Wilhelmus Kwanten
, et al.
·
Journal of Hepatology
·
1
Histomorphometry indicates distinct contributions of myofibroblast activation and sinusoidal capillarization to portal hypertension
2026
·
Thomas Sorz-Nechay
, Benedikt S. Hofer
, et al.
·
Hepatology International
PDF
Characterization of liver disease regression in murine models of liver fibrosis and portal hypertension
2026
·
Philipp Königshofer
, Ksenia Brusilovskaya
, et al.
·
Scientific Reports
FRI-431-YI LSECtin attenuation in cirrhosis correlates with disease severity and inflammation and can be experimentally recovered by IL-10/IL-13 administration
2026
·
Benedikt Simbrunner
, Oriol Juanola
, et al.
·
Journal of Hepatology
TOP-470-YI Longitudinal trajectories of IL-6 and vWF predict clinical outcomes in advanced chronic liver disease independent of liver function
2026
·
Georg Kramer
, Dalila Costa
, et al.
·
Journal of Hepatology
FRI-324 Lipometabolic reprogramming via ATGL inhibition improves liver fibrosis and promotes hepatic activated CD8+ tissue-resident memory T cells (TRM) in vivo
2026
·
Henriette Horstmeier
, Tanmoy Chakma
, et al.
·
Journal of Hepatology
THU-497-YI Contribution of myofibroblast activation and sinusoidal capillarization to portal hypertension
2026
·
Thomas Sorz-Nechay
, Benedikt Hofer
, et al.
·
Journal of Hepatology
OS-002-YI Hepatocyte lipolytic disruption by ATGL-deficiency contributes to MASH-fibrosis via lipotoxic stress in vivo: molecular and single-cell transcriptomic insights
2026
·
Henriette Horstmeier
, Tanmoy Chakma
, et al.
·
Journal of Hepatology
FRI-432 Characterization of the toll-like receptor ligandome across the clinical spectrum of alcohol-related cirrhosis
2026
·
Benedikt Simbrunner
, Raphaela Staltner
, et al.
·
Journal of Hepatology
TOP-325-YI Time-resolved single-cell profiling of liver fibrosis regression identifies monocyte-derived Kupffer cells as central mediators of resolution
2026
·
Katharina Bonitz
, Thomas Sorz-Nechay
, et al.
·
Journal of Hepatology
Show more works
View as search
Works count:
52
Citation count:
581
H-index:
6
I10-index:
4
Year
Topic
Type